193 related articles for article (PubMed ID: 28226199)
21. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
[TBL] [Abstract][Full Text] [Related]
22. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
23. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
[TBL] [Abstract][Full Text] [Related]
24. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
25. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
[TBL] [Abstract][Full Text] [Related]
26. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
[TBL] [Abstract][Full Text] [Related]
27. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
[TBL] [Abstract][Full Text] [Related]
28. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
[TBL] [Abstract][Full Text] [Related]
29. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
30. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
[TBL] [Abstract][Full Text] [Related]
31. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
32. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
Schaffer JM; Chiu P; Singh SK; Oyer PE; Reitz BA; Mallidi HR
Am J Transplant; 2014 Mar; 14(3):647-59. PubMed ID: 24517245
[TBL] [Abstract][Full Text] [Related]
33. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
34. Model for End-Stage Liver Disease-Sodium Score: The Evolution in the Prioritization of Liver Transplantation.
Machicao VI
Clin Liver Dis; 2017 May; 21(2):275-287. PubMed ID: 28364813
[TBL] [Abstract][Full Text] [Related]
35. Hyponatremia and mortality among patients on the liver-transplant waiting list.
Kim WR; Biggins SW; Kremers WK; Wiesner RH; Kamath PS; Benson JT; Edwards E; Therneau TM
N Engl J Med; 2008 Sep; 359(10):1018-26. PubMed ID: 18768945
[TBL] [Abstract][Full Text] [Related]
36. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
37. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
38. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
[TBL] [Abstract][Full Text] [Related]
39. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.
Asrani SK; Jennings LW; Kim WR; Kamath PS; Levitsky J; Nadim MK; Testa G; Leise MD; Trotter JF; Klintmalm G
Hepatology; 2020 May; 71(5):1766-1774. PubMed ID: 31523825
[TBL] [Abstract][Full Text] [Related]
40. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]